Morningside Ventures, one of China's earliest early-stage venture investors led a $102m Series D round in GreenLight Biosciences, a biotechnology company, with participation from S2G Ventures, Xeraya Capital, Cormorant Asset Management, Continental Grain Company, Fall Line Capital, Tao Capital Partners, Baird Capital, MLS Capital Fund II, Lewis and Clark AgriFood, and Lupa Systems. "GreenLight was born from a passion to make our world more sustainable and more equitable. We are honored to draw the support of this notable group of new and existing investors as we drive forward our dual mission to make food production more robust and environmentally respectful; and our health solutions applicable to every member of the human race," Andrey Zarur, GreenLight Co-founder and CEO.